THE decision to offer the under-30s an alternative to the AstraZeneca vaccine over blood clotting concerns has had no impact on people’s intention of getting the jab, new research by a Scottish university suggests. New UK guidance issued on April 7 recommended that people aged 18 to 29 should be offered the Pfizer or Moderna vaccines after the Medicines and Healthcare products Regulatory Agency (MHRA) said there was a possible link between the AstraZeneca jag and “extremely rare” blood clots. Several European countries, including France, Germany and Italy, suspended use of the vaccine last month, although they later said they would resume its rollout.
The majority of patients needing Covid care in hospital are now under 65 DEATHS from Covid have fallen to levels last seen in October, with hospitalisations for the disease among the elderly also continuing to shrink. The latest mortality figures from the National Records of Scotland come as the country prepares for the most substantial changes to lockdown since December, with shops, gyms, beauty salons and hospitality allowed to reopen from Monday and restrictions on travel to and from England and Wales due to end. In the week ending April 18, there were 24 deaths registered in Scotland where Covid was mentioned on the death certificate.
The decision to offer the under-30s an alternative to the AstraZeneca vaccine over blood clotting concerns has had no impact on people’s intention of getting the jab, new research suggests.
New UK guidance was issued on April 7 recommending that people aged 18 to 29 should be offered the Pfizer or Moderna vaccines after the Medicines and Healthcare products Regulatory Agency (MHRA) said there is a possible link between the AstraZeneca jab and “extremely rare” blood clots.
Several European countries including France, Germany and Italy suspended use of the vaccine in March over the link, although they later said they would resume its rollout.
MHRA regulator ruled this month that under-30s should be given a different jab
Survey of people aged 30 to 40 found they were not put off vaccination by news
They were close in age to those affected by rule but old enough to get AZ jab
Reputation of AstraZeneca s vaccine has suffered in Europe and Africa
Scientists say it appears to increase the risk of a very rare blood clotting illness
Change in AstraZeneca UK regulation for under 30s did not impact vaccine intentions stir.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stir.ac.uk Daily Mail and Mail on Sunday newspapers.